Germany· DE-A57-a73c5a12e11043e0
Repaglinid 1 A Pharma
A repaglinide product containing repaglinide, registered in Germany by 1 A Pharma Gmbh. The same ATC class is registered in 19 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Repaglinide is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BX02 (repaglinide), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Repaglinide · ATC A10BX02
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of repaglinide costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.30 in France to $1.47 in Switzerland — a ×4.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Repaglinide · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.47
- IT Italy$0.39
- FR France$0.30
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Repaglinide
- Manufacturer
- 1 A Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- A10BX02
- ATC class
- Repaglinide
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
708 interactions on record for repaglinide.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Repaglinide · interactions on record
708 records
- 18 severe
- 502 moderate
- 41 minor
- 145 info
Most severe, free to view
- ClopidogrelB01AC04severe
- GemfibrozilC10AB04severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Repaglinide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENYGLIDKrka, d.d., Novo mesto, Novo mesto
- United KingdomEnyglid 0.5mg tabletsKrka UK Ltd
- SpainEnyglid 0,5 mg comprimidos EFGKrka D.D. Novo Mesto
- IrelandEnyglid 0.5 mg tabletsKRKA, d.d., Novo mesto
- ItalyNOVONORMBB FARMA S.R.L.
- FranceNOVONORM 0,5 mg, compriméNOVO NORDISK (DANEMARK)
- BelgiumEnyglid 0.5 mgKRKA d.d. Novo mesto
- FinlandEnyglidKRKA d.d. Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
- Belgium · Repaglinide Eg
- Bulgaria · Индорин
- Cyprus · Theroflan
- Czechia · Vatinid
- Denmark · Repaglinid Doc Generici
- Spain · Repaglinida Alter, Repaglinida Aurovitas
- Finland · Repaglinid Stada
- France · Repaglinide Arrow Lab, Repaglinide Biogaran
- United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
- Greece · Theroflan
- Croatia · Reglinid, Repaglinid Pharmas
- Iceland · Enyglid, Novonorm
- Italy · Glicam, Repaglinide Aurobindo
- Liechtenstein · Repaglinide Teva
- Luxembourg · Repaglinide Eg
- Latvia · Repaglinide Elvim
- Malta · Repaglinide Aurobindo
- Netherlands · Repaglinide Stada
- Norway · Enyglid, Novonorm
- Romania · Reneos, Repaglinida Arena
- Sweden · Repaglinid Actavis, Repaglinid Stada
- Slovenia · Repaglinid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b6d22491-7201-4e70-8193-4e2135776327 GET /v1/drugs/b6d22491-7201-4e70-8193-4e2135776327?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Repaglinide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about repaglinide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.